Apellis Pharmaceuticals, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Apellis Pharmaceuticals, Inc.
CIK #0001492422
EDGAR Form CIK 2011 - 2025
10-K [0001492422]
10-Q [0001492422]
3 [0001492422]
4 [0001492422]
5 [0001492422]
8-K [0001492422]
D [0001492422]
SC 13G [0001492422]
Form 13D/13G Filer Form 13D/13G Subject Filed
Deep Track Capital LP Apellis Pharmaceuticals Inc [2025-05-16]
Morgan Stanley Apellis Pharmaceuticals Inc [2025-02-03]
Deep Track Capital LP Apellis Pharmaceuticals Inc [2024-11-22]
BlackRock Inc Apellis Pharmaceuticals Inc [2024-11-08]
BlackRock Inc Apellis Pharmaceuticals Inc [2024-10-18]
T Rowe Price Investment Management Inc Apellis Pharmaceuticals Inc [2024-02-14]
EcoR1 Capital LLC Apellis Pharmaceuticals Inc [2023-07-18]
T Rowe Price Investment Management Inc Apellis Pharmaceuticals Inc [2023-02-14]
Price T Rowe Associates Inc /MD/ Apellis Pharmaceuticals Inc [2022-02-14]
Avoro Capital Advisors LLC Apellis Pharmaceuticals Inc [2022-02-11]
View All
Form 3/4/5 Subject 2011 - 2025
Apellis Pharmaceuticals, Inc.
Watson David O.
Francois Cedric
Chopas James George
Deschatelets Pascal
Baumal Caroline
DeLong Mark Jeffrey
Sullivan Timothy Eugene
Nicholson Nur
Boucher Kelley
View All
Terms | Privacy | Guide
tony@aum13f.com